Cite

HARVARD Citation

    Chawla, S. et al. (n.d.). 1607PDImmune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy. Annals of oncology. p. . [Online]. 
  
Back to record